Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief ...

Pfizer has named company veteran Chris Boshoff, who led the drugmaker's cancer research and marketing for more than a year, ...

For Big Pharma, recent headlines out of China suggest multinational drugmakers are facing their share of challenges in the ...

Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics ...

NEW YORK, Nov 19 (Reuters) - A federal judge on Tuesday rejected Pfizer's (PFE.N), opens new tab bid to recoup about $75.2 million left over from a U.S. Securities and Exchange Commission insider ...

For Pfizer PFE0.58%increase; green up pointing triangle Chief Executive Officer Albert Bourla, the activist campaign launched by Starboard Value marks a pivotal moment in his career. For ...

Pfizer PFE0.97%increase; green up pointing triangle punched back against activist investor Starboard Value on Tuesday, delivering positive quarterly results. The pharmaceutical company raised its ...

Pfizer Inc.’s stock was unable to hold its early gains Tuesday and fell 2.4% after the company blew past estimates for the third quarter and raised its full-year guidance. The New York-based ...

Pfizer released earnings Tuesday that handily beat analyst expectations in the company’s first quarterly report since an activist investor took a $1 billion stake in the drug giant and began ...

A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the year. Demand for the drugmaker’s Paxlovid treatment spurred by the ...

There's some rumbling going on within Pfizer's investment community, as an activist hedge fund says that the company's performance has not been good enough. Pfizer has been in an anomalous ...